Exploring Galega officinalis and Its Relation to Metformin

Botanical illustration labeled Galega officinalis L. (Goat’s Rue, French Lilac), showing flowering stem, pinnate leaves, seed pods, flower details, and seeds.

Galega officinalis

Galega officinalis, commonly known as goat’s rue or French lilac, is a historically significant medicinal plant whose botanical characteristics, toxicological profile, traditional applications, and pharmacological connection to modern antidiabetic therapy make it both scientifically important and clinically cautionary.

Botanical Description and Toxicity

The botanical name of goat’s rue is Galega officinalis (GO). This herbaceous perennial belongs to the Fabaceae, or legume, family and is classified within the genus Galega. Native to North Africa, West Asia, and Europe, the species has expanded into several other regions, including Turkey, New Zealand, and South America. Although it has occasionally been cultivated as an ornamental plant and is valued by beekeepers as a nectar source, it is also recognized as an invasive weed and is highly toxic to livestock [1]. The plant typically reaches 5 to 8 ft in height and has hollow stems with pinnately arranged leaves containing 14 to 21 leaflets. It grows well in temperate climates and tolerates full sun, poor soils, and moist habitats. Its ability to reproduce through both root division and seed dispersal contributes to its aggressive spread in favorable environments. Despite its long-standing use in European folk medicine as a galactagogue, diuretic, and diaphoretic, GO presents substantial safety concerns. Its toxicity is thought to be associated with alkaloidal constituents and may be fatal to horses, cattle, and sheep. Reported pathological effects include hydrothorax, tracheal congestion, and cardiac collapse. Consequently, the plant is often classified as a noxious weed and is subject to eradication requirements in some jurisdictions. GO may also interact with prescribed medications, particularly antidiabetic agents and anticoagulants, and may influence iron absorption [2].

History of Traditional and Medical Uses

GO occupied a prominent position in European folk medicine, particularly after its inclusion in Nicholas Culpeper’s Complete Herbal (1653 AD), a widely known pharmacopoeia compiled by the English botanist and physician Nicholas Culpeper (1616–1654 AD). The plant has also been referred to by several alternative names, including false indigo, Spanish sanfoin, Italian fitch, and professor-weed. It produces white, blue, and purple flowers during summer and has spread globally over the past several centuries. Historically, GO was used in traditional medicine for the treatment of diabetes mellitus [3,4]. It was also prescribed as a diaphoretic during plague outbreaks, with the intention of inducing perspiration to reduce fever. Additional traditional uses included its application as a vermifuge, a treatment associated with epilepsy, and a topical anti-inflammatory compress for joint pain [5]. The plant was further valued by beekeepers because its flowers provide nectar for honey production, and it has also been claimed to function as a galactagogue.

Pharmacological Significance and Connection to Metformin

Modern scientific interest in GO has centered on its bioactive phytochemicals, particularly guanidine derivatives with glucose-lowering properties. The isolation of galegine, also known as isoamylene guanidine, and its experimental use in diabetes treatment during the 1920s represented an important pharmacological milestone. However, galegine was later replaced by safer and more effective therapies, including injectable insulin. The subsequent development of metformin, a synthetic biguanide also known as dimethyl biguanide, gave this historical line of investigation enduring medical significance. Metformin has become one of the most widely used oral medications for the management of type 2 diabetes worldwide [6]. This history illustrates the central paradox of Galega officinalis: although it is a toxic and invasive plant, its chemistry contributed to the development of one of the most important therapeutic approaches to diabetes.

Phytochemicals and Associated Biochemical Activities

Galega officinalis is best known for containing galegine, or isoamylene guanidine, a glucose-lowering bioactive compound that contributed to the development of the modern antidiabetic drug metformin, also known as dimethyl biguanide. Metformin is now widely used in the treatment of type 2 diabetes [7]. Galegine may reduce blood glucose by promoting peripheral tissue glucose uptake and delaying intestinal glucose absorption, while hydroxygalegine appears to contribute to related metabolic effects. However, these potentially beneficial properties are accompanied by significant toxicological concerns. Galegine has been associated with vascular effects, altered permeability, tissue fluid accumulation, mitochondrial energy disruption, and central nervous system depression [9]. Therefore, the pharmacological importance of GO must be considered together with its toxicity and clinical limitations. In addition to galegine, the plant contains quinazoline alkaloids and several antioxidant polyphenols. Major alkaloids include vasicine, also known as pegamine, and vasicinone, both of which have been investigated for anti-inflammatory activity and possible respiratory stimulant or bronchodilatory effects [10,11].

The plant is also rich in polyphenols, flavonoids, and phenolic acids, which contribute to antioxidant and free-radical-scavenging activities. Important flavonoids reported in GO include rutin, luteolin, hyperoside, and several quercetin glycosides, such as quercetin-3-O-robinoside and related derivatives [8]. These compounds support the plant’s biochemical relevance, although their therapeutic value requires careful interpretation because biological activity in extracts does not necessarily indicate clinical safety or efficacy.

Aqueous extracts contain several hydroxycinnamic acid esters derived from caffeic acid, ferulic acid, and chicoric acid [8]. These phenolic constituents may contribute to the plant’s antioxidant profile and help explain its continued interest in phytochemical research.

Saponins have also been identified in GO, including derivatives of soyasapogenols, which are characteristic triterpenoid compounds found in members of the Fabaceae family. These pentacyclic oleanane-type triterpenoids are associated with biological effects on membrane dynamics, lipid metabolism, and intracellular signaling pathways. Some studies suggest that related compounds may influence muscle metabolism and broader metabolic health, although such effects should be described cautiously and distinguished from established clinical outcomes [12].

Allantoin and medicagol have also been reported in the aerial parts of the plant. Allantoin is commonly associated with oxidative stress responses because it is formed through uric acid oxidation. It has also been linked to fibroblast proliferation, extracellular matrix formation, and modulation of inflammatory mediators [13]. Medicagol, a polycyclic coumestan-type flavonoid, has been examined for potential antidiabetic activity through inhibition of carbohydrate-hydrolyzing enzymes. This activity may reduce postprandial hyperglycemia and may also be associated with improvements in lipid metabolism, insulin resistance, and oxidative stress markers in experimental models. In addition, GO contains several uncharacterized tannins that may act synergistically by inhibiting α-amylase, an enzyme involved in carbohydrate breakdown and glucose release [14,15]. Soyasapogenols are bioactive oleanane-type triterpenoid aglycone saponins that have been associated with effects on muscle metabolism, tumor-related pathways, and metabolic regulation [12]. Beta-sitosterol, a phytosterol, has been reported to reduce blood cholesterol levels and lower the risk of benign prostatic hyperplasia (BPH). It also serves as a precursor in the synthesis of anabolic steroids [16].

Pharmacological Effects and Clinical Caution

Overall, Galega officinalis demonstrates a complex pharmacological profile. Its historical use in diabetes and its chemical relationship to metformin make it an important example of how traditional medicinal plants can influence modern drug discovery. At the same time, its toxicity to livestock, possible interactions with prescribed medicines, and uncertain safety in direct human use require extreme caution. For this reason, GO should be viewed primarily as a plant of historical, phytochemical, and pharmacological significance rather than as a safe self-administered herbal treatment.

Antidiabetic effect

GO has considerable relevance to diabetes research because its guanidine-derived constituents influenced the development of metformin, one of the most widely prescribed medications for type 2 diabetes. Although the plant itself has demonstrated glucose-lowering activity, its raw form is associated with substantial toxicity and should not be recommended as an herbal treatment. Nevertheless, its historical and biochemical relationship to diabetes continues to stimulate interest in modified or isolated compounds. Galegine, the principal antidiabetic constituent, is a guanidine derivative that is structurally related to metformin. In animal models, GO extracts have also shown cytoprotective effects, including enlargement of the islets of Langerhans and protection of insulin-producing pancreatic β-cells from oxidative injury. These effects may be mediated through antioxidant mechanisms and increased activity of endogenous antioxidant enzymes such as superoxide dismutase and catalase. In addition, galegine, like metformin, may inhibit hepatic gluconeogenesis, thereby reducing hepatic glucose production and improving tissue insulin sensitivity in the context of type 2 diabetes [17].

Antioxidant effect

GO extracts may attenuate oxidative stress through several mechanisms, including free-radical scavenging, activation of endogenous antioxidant defense enzymes such as SOD, CAT, and GPX, and suppression of excess reactive oxygen species production in leukocytes. These mechanisms may help protect hepatocytes, particularly under diabetic conditions. GO extracts may also inhibit oxidative modification of cellular proteins and lipids by interrupting free-radical chain reactions [18]. In addition to galegine, polyphenolic constituents such as quercetin, rutin, chlorogenic acid, and related compounds may contribute to antioxidant activity through electron transfer and metal chelation. Tannins, phytol, and quinazoline alkaloids may further enhance these effects through synergistic biochemical interactions [8].

Cardiovascular and Platelet Functions

Although GO is best known for its glucose-lowering properties, extracts of the plant have also demonstrated antiplatelet activity, suggesting possible cardiovascular relevance. Studies have reported that GO extracts inhibit platelet aggregation [19]. Both crude extracts and isolated fractions have been shown to suppress ADP-induced aggregation (IC50 approximately 11.2 µg/ml), collagen-induced aggregation (IC50 approximately 15.1 µg/ml), and thrombin-induced aggregation (IC50 approximately 19.6 µg/ml). Fractionation of aqueous extracts has yielded glycoproteins with molecular weights of 100–140 kDa that exhibit anticoagulant activity. These bioactive proteins contain peptide sequences such as RGD (Arg-Gly-Asp), RGDS (Arg-Gly-Asp-Ser), and KRDS (Lys-Arg-Asp-Ser), which resemble fibrinogen recognition motifs that interact with platelet glycoprotein IIb/IIIa receptors. By binding to these receptors, GO-derived peptides may prevent fibrinogen interaction with platelets and thereby inhibit clot formation or thrombosis [20]. Experimental animal studies have also reported transient reductions in blood pressure following exposure to GO extracts, an effect that may be related to the alkaloid galegine [21].

Diuretic and Weight Management Effects

Historically, European folk medicine described GO extracts as mild diuretics and digestive tonics. In animal studies, galegine has shown modest weight-reducing effects that resemble some metabolic actions of metformin, a synthetic biguanide. These effects may be related to reduced intestinal glucose absorption, decreased food intake, and associated improvements in cardiovascular risk factors [22]. However, such findings remain experimental and should not be interpreted as evidence supporting unsupervised use of the plant for weight management.

Galactagogue Effect/ Enhancement of Lactation

Traditional use suggests that GO may enhance lactation, although definitive clinical evidence from controlled human studies is lacking [23]. Despite the limited clinical support, pharmacological and anecdotal reports have proposed potential mechanisms for a galactagogue effect. Galegine has been suggested to stimulate development of mammary tissue and milk-producing cells, thereby potentially enhancing milk production. Herbal practitioners have also recommended GO for individuals with insufficient glandular tissue or those experiencing polycystic ovary syndrome [24,25]. These claims should be interpreted cautiously because efficacy and safety have not been firmly established in rigorous clinical studies.

Anti-inflammatory effect

GO exhibits anti-inflammatory activity by modulating pro-inflammatory cell-signaling pathways, reducing inflammatory cytokine production, and alleviating oxidative stress [26]. Galegine has been reported to inhibit the generation of TNF-α and IL-1β, processes that are particularly relevant during wound healing [27]. GO extracts may also prevent excessive nitric oxide production, thereby contributing to cellular protection [28]. Non-alkaloid anti-inflammatory constituents include α-amyrin and the methyl ester of linolenic acid, while flavonoids may provide additional immunomodulatory effects through reduction of oxidative stress [26].

Anticancer role

Dichloromethane extracts of GO have demonstrated cytotoxic effects against several human cancer cell lines, including lung carcinoma (A549), colon adenocarcinoma (HT-29 and DLD-1), and glioblastoma (U-87). Dichloromethane extraction has been reported to produce more potent activity than extraction with other solvents [29]. These extracts have been described as inducing apoptosis in cancer cell lines and limiting cellular proliferation, although claims regarding selectivity toward cancer cells over normal tissues require careful verification [26]. Flavonoids, phytol, and linolenic acid esters may contribute to these effects through antioxidant mechanisms that reduce oxidative stress and DNA damage associated with carcinogenesis [30].

The potential anticancer relevance of galegine and its close pharmacological analogue, metformin, remains incompletely defined. Metformin can activate the AMPK pathway and inhibit mTOR, a serine/threonine protein kinase involved in cellular growth and energy metabolism, thereby potentially limiting energy availability to cancer cells. However, preliminary clinical studies in breast cancer have produced mixed results [31]. Thus, the possible anticancer role of GO is more appropriately attributed to the combined antioxidant and anti-inflammatory activities of its phytochemical constituents rather than to a clearly established clinical anticancer effect.

Effect on Reproductive System

GO has traditionally been recognized as a galactagogue, but experimental studies also suggest possible effects on reproductive physiology. In rat models of polycystic ovary syndrome, GO extracts have been reported to modulate reproductive hormones by lowering LH, FSH, and testosterone levels while helping restore estrogen levels and follicle counts [32]. These endocrine changes may be related to improved glucose regulation and reduced insulin resistance, mechanisms that resemble some actions of metformin. Animal studies have also indicated antioxidant-mediated protection of reproductive tissues. In diabetic male rats, GO extracts may help preserve testicular structure and support spermatogenesis by reducing oxidative stress. Similarly, in female models, the extracts may protect ovarian tissue from oxidative injury [33,34].

Toxicity

Galega officinalis is a toxic plant and is risky for human consumption [35]. The major toxic ingredient is galegine, a guanidine alkaloid present in all plant parts, including leaves, stems, and seeds [36]. Galegine levels peak during the immature pod stage and the flowering season. Galegine is heat-resistant and remains intact even in dried form. In the 1920s, it was briefly used to control diabetes but was quickly banned because of its severe toxicity. The compound is a neurotoxin and a hypotensive agent. It disrupts the CNS, causing cardiovascular and pulmonary complications, including pulmonary edema, which fills the lungs with fluid and produces severe respiratory distress [37]. Most animals, including humans, are extremely vulnerable, particularly horses [38].

Bibliography

  1. Lasseigne A. “Invasive Plants of the Eastern United States: Galega”. US Dept of Agri. 2003/11/03.
  2. Nathan D M, Buse J B, Davidson M B et al. Diabetes Care, 2009, 32 (1), 193 – 203. https://doi.org/10.2337%2Fdc08-9025
  3. https://publications.aston.ac.uk/id/eprint/31353/1/Metformin_history.pdf
  4. https://www.goodrx.com/metformin/history
  5. Darbyshire S J, Francis A, Bromfield E S P. et al. Canad J Plant Sci. 2022, 102 (1), https://doi.org/10.1139/cjps-2020-0327
  6. Bailey C J. Diabetologia, 2017, 60(9), 1566 – 1576. https://doi.org/10.1007/s00125-017-4318-z
  7. https://chiro.org/Graphics_Box_NUTRITION/FULL/PHYTOCHEMICALS/LIST_OF_PLANTS/Goat-Rue.html
  8. Bednarska K, Kus P, Fecka I. Molecules, 2020, 25(24), 5810. https://doi.org/10.3390/molecules25245810
  9. Wang W, Zhang X. Molecules, 2021, 26(1), 4830. https://doi.org/10.3390/molecules26164830
  10. Avula B et al. Die Pharmazie, 2008, 63(1), 20 – 22. https://doi.org/10.1691%2Fph.2008.7175
  11. Rajani M, Soni S, Anandjiwala S et al. Ind J Pharma Sci. 2008, 70(1), 36 – 42. https://doi.org/10.4103%2F0250-474X.40329
  12. Ahn B M, Noh Y, Lee J J et al. Biomed Pharmacotherp, 2025, 189, 118316. https://doi.org/10.1016/j.biopha.2025.118316
  13. https://www.hmdb.ca/metabolites/HMDB0000462
  14. Shahzad A, Liu W, Hussain S et al. Sci Rep, 2025, 15(1), 6620. https://doi.org/10.1038/s41598-025-89642-5
  15. Luka C D, Omoniwa B P. J Nat Prod Plant Resour, 2012, 2(5), 628 – 632.
  16. Kim T H, Lim H J, Kim M S et al. Maturitas, 2012, 73(3), 180 – 185. https://doi.org/10.1016%2Fj.maturitas.2012.07.007
  17. Maruthur N M, Tseng E, Hutfless S et al. Annals of Internal Med, 2016, 164 (11), 740 – 751. https://doi.org/10.7326%2FM15-2650
  18. Lupak M I, Khokha M R, Hachkova G Y et al. Ukr Biochem J, 2015, 87(4), 78 – 86.
  19. Atanasov A T, Tchorbanov B. J Med Food, 2002, 5(4), 229 – 234. https://doi.org/10.1089/109662002763003384
  20. Atanasov A T, Chorbanov B P, Dimitrov B D. Folia Medica XLIV, 1&2/2002.
  21. https://caringsunshine.com/ingredients/ingredient-goat-s-rue
  22. Jaffe R. Bioactive Food as Dietary Inter Diabetes, Ch-30, “Phytonutrients in Diabetes Management”, 2013, Elsevier Inc. http://dx.doi.org/10.1016/B978-0-12-397153-1.00037-8
  23. Bazzano A N, Hofer R, Thibeau S et al. Ochsner J, 2016, 16(4), 511-524.
  24. https://milky-mama.com/blogs/milk-supply-guide/does-goats-rue-increase-milk-supply-what-you-need-to-know
  25. https://www.ncbi.nlm.nih.gov/books/NBK501817/
  26. Nagalievska M, Sabadshka M, Hachkova H, Sybirna N. BMC Comple Altern Med, 2018, 18(1), 4. https://doi.org/10.1186/s12906-017-2079-3
  27. Shojaeian A. J Wound Manag Res, 2024, 20(3), 212 – 218, https://doi.org/10.22467/jwmr.2024.02957
  28. https://ayurtimes.com/goats-rue-galega-officinalis/
  29. Karakas F P, Turker A U, Karakas A et al. Trop J Pharma Res, 2016, 15(4), 751 – 757.
  30. Hachkova H, Nagalievska M, Solijak Z et al. Antioxidants 2021, 10(9), 1362.   https://doi.org/10.3390/antiox10091362
  31. Pal R S, Jawaid T, Rahman M A et al. Biochimie, 2025, 233, 109 – 121. https://doi.org/10.1016/j.biochi.2025.03.002
  32. Abtahi-Eivari S H, Monghimian M, Soltani M et al. Int J Women’s Health Reprod Sci. 2018, 6(3), 276 – 282,
  33. Shokri F, Shokoohi M, Abadi A R R et al. Int J Women’s Health Reprod Sci. 2019, 7(1), 119 – 123.
  34. Shokri F, Shokoohi M, Niazkar H R et al. Crescent J Med Biol Sci, 2019, 6(1), 31 – 36.
  35. https://poisonousplants.cvmbs.colostate.edu/plant/126
  36. Anadon A, Martinez-Larranaga M R, Castellano V. Veterniary Toxicol, 2nd Edition; “Poisnous plants of Europe” Ch-78, Ed: Ramesh C Gupta; 2012, Elsevier. http://dx.doi.org/10.1016/B978-0-12-385926-6.00114-9
  37. Rasekh H, Nazari P, Kamil-Nejad M. Hossainzadeh L. J Ethnopharmacol, 2008, 116(1), 21 – 26. https://doi.org/10.1016/j.jep.2007.10.030
  38. Blanchard T, Fantinati M, Domange C et al. J Equine Vet Sci, 2022, 117, 104084. https://doi.org/10.1016/j.jevs.2022.104084

Leave a Reply